论文部分内容阅读
目的总结血塞通注射液与前列地尔注射液治疗糖尿病足的具体疗效,进行效果对比分析。方法选择2015年3月-2016年12月住院治疗的82例糖尿病足患者,均接受常规治疗。随机分为采取血塞通注射液联合硫酸锌注射液治疗的实验1组(41例)以及前列地尔注射液联合硫酸锌注射液治疗的实验2组(41例),对比两组糖尿病足患者的临床治疗效果。结果实验1组糖尿病足患者治疗总有效率为87.80%,实验2组糖尿病足患者治疗总有效率为85.36%。经统计学计算,差异无统计学意义(P>0.05)。结论针对糖尿病足,采取血塞通注射液、前列地尔注射液联合其他治疗方案在效果方面,差异无统计学意义(P>0.05),均利于患者临床治疗以及治疗预后效果的实现,具有临床实施价值。
Objective To summarize the specific curative effect of Xuesaitong injection and alprostadil injection on the treatment of diabetic foot, and to compare the effects. Methods Eighty-two patients with diabetic foot admitted to hospital from March 2015 to December 2016 were enrolled in the routine treatment. The patients in experimental group 1 (41 cases) treated with Xuesaitong injection combined with zinc sulfate injection and the experimental group 2 (41 cases) treated with alprostadil injection and zinc sulfate injection were compared. The clinical treatment effect. Results The total effective rate was 87.80% in experimental group 1 diabetic foot, and 85.36% in experimental group 2 diabetic foot. After statistical calculation, the difference was not statistically significant (P> 0.05). Conclusion For the diabetic foot, taking Xuesaitong injection and prostaglandin injection in combination with other treatments have no significant difference in the effect (P> 0.05), which are beneficial to the clinical treatment of patients and the realization of the prognosis of treatment, Implementation value.